Medicare Enrolled
Dr. Avtar Parhar, MD FCCP
Pulmonary Disease · Holmdel, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parhar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parhar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parhar
Dr. Avtar Parhar is a pulmonary disease specialist in Holmdel, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Parhar performed 8,779 Medicare services across 4,606 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parhar received a total of $17,587 from 56 pharmaceutical and/or device companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parhar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NJ
$17,587 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,779
Medicare services
Top 1% in NJ for pulmonary disease
4,606
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~439 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
1,776 | $67 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,431 | $66 | $175 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
926 | $11 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
827 | $100 | $250 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
767 | $9 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
280 | $99 | $250 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
273 | $84 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
244 | $137 | $181 |
| Annual depression screening | 228 | $20 | $50 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
225 | $22 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
224 | $33 | $40 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
151 | $62 | $100 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
144 | $1 | $25 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
142 | $15 | $50 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
141 | $8 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
132 | $32 | $400 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
132 | $37 | $100 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
132 | $47 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $132 | $350 |
| Pneumococcal vaccine, 23-valent A vaccine that protects against 23 types of pneumococcal bacteria. It is used to prevent infections caused by these bacteria. |
58 | $131 | $150 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
58 | $33 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
50 | $107 | $350 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
48 | $111 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $145 | $500 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
41 | $68 | $250 |
| Nursing facility visit, established patient, straightforward A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves straightforward medical decision making and lasts at least 10 minutes. |
39 | $33 | $75 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
38 | $45 | $125 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
33 | $236 | $400 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
32 | $172 | $300 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $148 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
24 | $12 | $60 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
20 | $38 | $150 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
19 | $175 | $270 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
13 | $176 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,587
Total received (2018-2024)
Avg $2,512/year across 7 years
Top 6% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
334
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,843 (56.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,744 (44.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$749
2023
$1,042
2022
$1,021
2021
$846
2020
$6,699
2019
$4,561
2018
$2,669
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$404
Insmed, Inc.
$116
United Therapeutics Corporation
$46
Phathom Pharmaceuticals, Inc.
$31
Pulmonx Corporation
$27
Philips North America LLC
$23
Exact Sciences Corporation
$20
Mylan Specialty L.P.
$19
Janssen Pharmaceuticals, Inc
$17
Electromed, Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Lilly USA, LLC
$15
Top 3 companies account for 75.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$9,743
Veran Medical Technologies, Inc.
$1,928
AstraZeneca Pharmaceuticals LP
$1,885
Philips Electronics North America Corporation
$361
Regeneron Healthcare Solutions, Inc.
$243
PFIZER INC.
$227
Novo Nordisk Inc
$196
Covidien LP
$195
ABBVIE INC.
$191
Electromed, Inc.
$183
GlaxoSmithKline, LLC.
$144
Bayer HealthCare Pharmaceuticals Inc.
$142
GENZYME CORPORATION
$140
United Therapeutics Corporation
$135
E.R. Squibb & Sons, L.L.C.
$123
Insmed, Inc.
$116
Genentech USA, Inc.
$91
Teva Pharmaceuticals USA, Inc.
$90
Abbott Laboratories
$85
Boston Scientific Corporation
$83
Takeda Pharmaceuticals U.S.A., Inc.
$80
Janssen Pharmaceuticals, Inc
$72
Mallinckrodt Hospital Products Inc.
$70
Exact Sciences Corporation
$69
Mylan Specialty L.P.
$68
Eisai Inc.
$67
Nonin Medical, Inc.
$61
TOPCON HEALTHCARE SOLUTIONS, INC.
$54
Avanir Pharmaceuticals, Inc.
$53
Horizon Therapeutics plc
$52
Gilead Sciences, Inc.
$50
Nabriva Therapeutics, plc
$45
Lilly USA, LLC
$43
Mallinckrodt Enterprises LLC
$42
Supernus Pharmaceuticals, Inc.
$35
Phathom Pharmaceuticals, Inc.
$31
Esperion Therapeutics, Inc.
$30
Amgen Inc.
$29
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
Jazz Pharmaceuticals Inc.
$29
SANOFI-AVENTIS U.S. LLC
$28
Pulmonx Corporation
$27
AbbVie Inc.
$26
Philips North America LLC
$23
Novartis Pharmaceuticals Corporation
$17
Resmed Corp
$16
Allergan, Inc.
$16
Biogen, Inc.
$15
Mallinckrodt LLC
$15
Allergan Inc.
$15
Shire North American Group Inc
$14
Medtronic, Inc.
$14
Paratek Pharmaceuticals, Inc.
$13
Aytu BioScience, Inc
$13
Amarin Pharma Inc.
$13
Circassia Pharmaceuticals Inc
$12
Top 3 companies account for 77.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ARALAST · AUSTEDO · AVONEX · Adempas · Aimovig · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · CHARTIS CATHETER · COLOGUARD DNA CAPTURE REAGENTS · CUVITRU · Cologuard Collection Kit · DUEXIS · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · FARXIGA · FASENRA · FIASP · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GLASSIA · HARMONY · JARDIANCE · LOKELMA · NEXLETOL · NUCALA · NUEDEXTA · NUZYRA · Natesto · OFEV · ORENITRAM · Ozempic · PENNSAID · PROAIR · ProAir Digihaler · QULIPTA · RAYOS · Repatha · Respiratoriy Care Undiv · Rybelsus · SMARTVEST · SPIRIVA RESPIMAT · SUNOSI · SUPERION · SYMBICORT · Spin · SuperDimension · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TROKENDI XR · TUDORZA PRESSAIR · TYVASO · Tresiba · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Wellcentive Undiv · XARELTO · XIFAXAN · Xenleta · Xofluza · Xolair · YUPELRI · Yupelri · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for pulmonary disease in NJ.
Geographic Context
Pulmonary diseases within 10 mi
180
Per 100K population
28.0
County median income
$122,727
Nearest hospital
BAYSHORE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parhar is a clinical cardiology specialist, with above-average Medicare volume (top 1% in NJ), with speaking/promotional industry engagement in the top 6% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parhar experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Parhar performed 1,776 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parhar receive payments from pharmaceutical companies?
Yes. Dr. Parhar received a total of $17,587 from 56 companies across 334 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parhar's costs compare to other pulmonary diseases in Holmdel?
Dr. Parhar's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parhar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Holmdel
Browse pulmonary diseases in Holmdel ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Veran Medical Technologies, Inc. Payments to Doctors
See all physicians who received payments from Veran Medical Technologies, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology